In a strongly worded letter, Caroline Kennedy urged the Senate to reject Robert F. Kennedy Jr. for the role of Health and ...

RFK Jr. played a lead role in building an case against Merck's HPV vaccine and could profit from the lawsuit alleging fraud, ...

Merck (MRK) announced that the board of directors has declared a quarterly dividend of 81c per share of the company’s common stock for the ...

Robert F. Kennedy Jr. is not qualified to be health and human services secretary for many reasons, chief among them being his ...

We recently published a list of Kevin O’Leary’s Stock Portfolio: 15 Stock Picks for 2025. In this article, we are going to ...

Citi lowered the firm’s price target on Merck (MRK) to $125 from $130 and keeps a Buy rating on the shares. Ahead of the Q4 earnings, the firm ...

Co., Inc. (NYSE:MRK), a global healthcare leader, declared on Monday a quarterly dividend and a substantial stock repurchase ...

Unlike Bobby, I try not to speak for my father – but I am certain that he and my uncle Bobby, who gave their lives in public ...

Exelixis (EXEL) has recently gained traction in the rapidly growing oncology market with its promising pipeline and strong ...

The daughter of former President John F. Kennedy is speaking out against Health and Human Services Secretary designate Robert F. Kennedy Jr., lambasting her cousin as a “predator” with “dangerous” ...

Robert F. Kennedy Jr. has built his fortune and reputation on disparaging the government scientists and institutions he's now ...

Merck & Co Inc (MRK) stock saw a modest uptick, ending the day at $97.94 which represents a slight increase of $2.39 or 2.50% from the prior close of $95.55. The stock opened at $96.63 and touched a ...